Hofbauer, Lorenz C.

Osteoporosis: now and the future

Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 2,696

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,805

Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1

Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 794

Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology

Bone Metabolism and DiseasesEstrogen and related hormone effects

Cited by 692

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 586

The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss

Eskan, M. A., Jotwani, R., Abe, T., Chmelar, J., Lim, J.-H., Liang, S., Ciero, P. A., Krauss, J. L., Li, F., Rauner, M., et al. (2012) · Nature Immunology

Oral microbiology and periodontitis researchCell Adhesion Molecules Research

Cited by 429

Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial

Bischoff-Ferrari, H. A., Vellas, B., Rizzoli, R., Kressig, R. W., da Silva, J. A. P., Blauth, M., Felson, D. T., McCloskey, E. V., Watzl, B., Hofbauer, L. C., et al. (2020) · JAMA

Vitamin D Research StudiesNutrition and Health in Aging

Cited by 353

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma

Eisenhofer, G., Lenders, J. W., Timmers, H., Mannelli, M., Grebe, S. K., Hofbauer, L. C., Bornstein, S. R., Tiebel, O., Adams, K., Bratslavsky, G., et al. (2011) · Clinical Chemistry

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 290

RANK ligand and osteoprotegerin in myeloma bone disease.

Sezer, O., Heider, U., Zavrski, I., Kühne, C. A., & Hofbauer, L. C. (2003) · Blood

Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments

Cited by 258

Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells

Streicher, C., Heyny, A., Andrukhova, O., Haigl, B., Slavic, S., Schüler, C., Kollmann, K., Kantner, I., Sexl, V., Kleiter, M., et al. (2017) · Scientific Reports

Bone Metabolism and DiseasesEstrogen and related hormone effects

Cited by 251

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Keller, J., Catala-Lehnen, P., Huebner, A. K., Jeschke, A., Heckt, T., Lueth, A., Krause, M., Koehne, T., Albers, J., Schulze, J., et al. (2014) · Nature Communications

Bone Metabolism and DiseasesSphingolipid Metabolism and Signaling

Cited by 211

Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.

Viereck, V., Gründker, C., Blaschke, S., Niederkleine, B., Siggelkow, H., Frosch, K.-H., Raddatz, D., Emons, G., & Hofbauer, L. C. (2003) · The Journal of Clinical Endocrinology & Metabolism

Bone Metabolism and DiseasesEstrogen and related hormone effects

Cited by 110

Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling

Rauner, M., Baschant, U., Roetto, A., Pellegrino, R. M., Rother, S., Salbach-Hirsch, J., Weidner, H., Hintze, V., Campbell, G., Petzold, A., et al. (2019) · Nature Metabolism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 87

Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.

Dobnig, H., Hofbauer, L. C., Viereck, V., Obermayer-Pietsch, B., & Fahrleitner-Pammer, A. (2006) · Osteoporosis International

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 76

Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn’s disease.

von Tirpitz, C., Epp, S., Klaus, J., Mason, R., Hawa, G., Brinskelle-Schmal, N., Hofbauer, L. C., Adler, G., Kratzer, W., & Reinshagen, M. (2003) · European Journal of Gastroenterology & Hepatology

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 69

Osteoprotegerin expression in dendritic cells increases with maturation and is NF‐κB‐dependent

Schoppet, M., Henser, S., Ruppert, V., Stübig, T., Al‐Fakhri, N., Maisch, B., & Hofbauer, L. C. (2007) · Journal of Cellular Biochemistry

Immunotherapy and Immune ResponsesImmune Response and Inflammation

Cited by 45

Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency

Auer, M. K., Paizoni, L., Hofbauer, L. C., Rauner, M., Chen, Y., Schmidt, H., Huebner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 33

Effects of insulin therapy on porosity, non-enzymatic glycation and mechanical competence in the bone of rats with type 2 diabetes mellitus

Campbell, G. M., Tiwari, S., Picke, A.-K., Hofbauer, C., Rauner, M., Morlock, M. M., Hofbauer, L. C., & Glüer, C.-C. (2016) · Bone

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 11

Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts

Lademann, F., Rijntjes, E., Köhrle, J., Tsourdi, E., Hofbauer, L. C., & Rauner, M. (2024) · Communications Biology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 8